|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Colak S and Ten Dijke P: Targeting TGF-β
signaling in cancer. Trends Cancer. 3:56–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Batlle E and Massagué J: Transforming
growth factor-β signaling in immunity and cancer. Immunity.
50:924–940. 2018. View Article : Google Scholar
|
|
5
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 23:77–82. 2015.
|
|
6
|
Sun D, Zhuang X, Zhang S, Deng ZB, Grizzle
W, Miller D and Zhang HG: Exosomes are endogenous nanoparticles
that can deliver biological information between cells. Adv Drug
Deliv Rev. 65:342–347. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
OBrien K, Breyne K, Ughetto S, Laurent LC
and Breakefield XO: RNA delivery by extracellular vesicles in
mammalian cells and its applications. Nat Rev Mol Cell Biol.
21:585–606. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kurywchak P and Kalluri R: An evolving
function of DNA-containing exosomes in chemotherapy-induced immune
response. Cell Res. 27:722–723. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barile L and Vassalli G: Exosomes: Therapy
delivery tools and biomarkers of diseases. Pharmacol Ther.
174:63–78. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Veerman RE, Güçlüler Akpinar G, Eldh M and
Gabrielsson S: Immune cell-derived extracellular vesicles-functions
and therapeutic applications. Trends Mol Med. 25:382–394. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang X, Yuan X, Shi H, Wu L, Qian H and
Xu W: Exosomes in cancer: Small particle, big player. J Hematol
Oncol. 8:832015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
13
|
Shenoy A and Blelloch RH: Regulation of
microRNA function in somatic stem cell proliferation and
differentiation. Nat Rev Mol Cell Biol. 15:565–576. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wong CM, Tsang FH and Ng IO: Non-coding
RNAs in hepatocellular carcinoma: Molecular functions and
pathological implications. Nat Rev Gastroenterol Hepatol.
15:137–151. 2017. View Article : Google Scholar
|
|
15
|
Lorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
7:848–856. 2009.
|
|
16
|
Tugay K, Guay C, Marques AC, Allagnat F,
Locke JM, Harries LW, Rutter GA and Regazzi R: Role of microRNAs in
the age-associated decline of pancreatic beta cell function in rat
islets. Diabetologia. 59:161–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qureshi R, Arora H and Rizvi MA: EMT in
cervical cancer: Its role in tumour progression and response to
therapy. Cancer Lett. 356:321–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pastushenko I and Blanpain C: EMT
translation states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang J, Antin P, Berx G, Blanpain C,
Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori
G, et al: Guidelines and definitions for research on
epithelial-mesenchymal transition. Nat Rev Mol Cell Biol.
21:341–352. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei SC and Yang J: Forcing through tumor
metastasis: The interplay between tissue rigidity and
epithelial-mesenchymal transition. Trends Cell Biol. 26:111–120.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu F, Zhang J, Hu G, Liu L and Liang W:
Hypoxia and TGF-β1 induced PLOD2 expression improve the migration
and invasion of cervical cancer cells by promoting
epithelial-to-mesenchymal transition (EMT) and focal adhesion
formation. Cancer Cell International. 17:542017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Xing T, Chen Y and Xiao J:
Exosome-mediated miR-200b promotes colorectal cancer proliferation
upon TGF-β1 exposure. Biomed Pharmacother. 106:1135–1143. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang M, Jia M and Yuan K: MicroRNA-663b
promotes cell proliferation and epithelial mesenchymal transition
by directly targeting SMAD7 in nasopharyngeal carcinoma. Exp Ther
Med. 16:3129–3134. 2018.PubMed/NCBI
|
|
25
|
Wang YL, Shen Y, Xu JP, Han K, Zhou Y,
Yang S, Yin JY, Min DL and Hu HY: Pterostilbene suppresses human
endometrial cancer cells in vitro by down-regulating miR-663b. Acta
Pharmacol Sin. 38:1394–1400. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shu Y, Ye W, Gu YL and Sun P: Blockade of
miR-663b inhibits cell proliferation and induces apoptosis in
osteosarcoma via regulating TP73 expression. Bratisl Lek Listy.
119:41–46. 2018.PubMed/NCBI
|
|
27
|
Stanley P: Biological consequences of
overexpressing or eliminating N-acetylglucosaminyltransferase-TIII
in the mouse. Biochim Biophys Acta. 1573:363–368. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang H, Liu Y, Yu P, Qu J, Guo Y, Li W,
Wang S and Zhang J: MiR-23a transcriptional activated by Runx2
increases metastatic potential of mouse hepatoma cell via directly
targeting Mgat3. Sci Rep. 8:73662018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pinho SS, Reis CA, Paredes J, Magalhães
AM, Ferreira AC, Figueiredo J, Xiaogang W, Carneiro F, Gärtner F
and Seruca R: The role of N-acetylglucosaminyltransferase III and V
in the post-transcriptional modifications of E-cadherin. Hum Mol
Genet. 18:2599–2608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kohler RS, Anugraham M, López MN, Xiao C,
Schoetzau A, Hettich T, Schlotterbeck G, Fedier A, Jacob F and
Heinzelmann-Schwarz V: Epigenetic activation of MGAT3 and
corresponding bisecting GlcNAc shortens the survival of cancer
patients. Oncotarget. 7:51674–51686. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoshimura M, Ihara Y, Matsuzawa Y and
Taniguchi N: Aberrant glycosylation of E-cadherin enhances
cell-cell binding to suppress metastasis. J Biol Chem.
271:13811–13815. 2016. View Article : Google Scholar
|
|
32
|
Ha D, Yang N and Nadithe V: Exosomes as
therapeutic drug carriers and delivery vehicles across biological
membranes: Current perspectives and future challenges. Acta Pharm
Sin B. 6:287–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren
X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, et al:
Exosomes as a tumor immune escape mechanism: Possible therapeutic
implications. J Transl Med. 6:372008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Devhare PB, Sasaki R, Shrivastava S, Di
Bisceglie AM, Ray R and Ray RB: Exosome-mediated intercellular
communication between hepatitis C virus-infected hepatocytes and
hepatic stellate cells. Virol. 91:e02225–16. 2017. View Article : Google Scholar
|
|
35
|
Neuzillet C, De Gramont A,
Tijeras-Raballand A, de Mestier L, Cros J, Faivre S and Raymond E:
Perspectives of TGF-β inhibition in pancreatic and hepatocellular
carcinomas. Oncotarget. 5:78–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huynh LK, Hipolito CJ and Ten Dijke P: A
perspective on the development of TGF-β inhibitors for cancer
treatment. Biomolecculars. 9:7432019. View Article : Google Scholar
|
|
37
|
Park SJ, Choi YS, Lee S, Lee YJ, Hong S,
Han S and Kim BC: BIX02189 inhibits TGF-β1-induced lung cancer cell
metastasis by directly targeting TGF-β type I receptor. Cancer
Lett. 381:314–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim S, Lee J, You D, Jeong Y, Jeon M, Yu
J, Kim SW, Nam SJ and Lee JE: Berberine suppresses cell motility
through downregulation of TGF-β1 in triple negative breast cancer
cells. Cell Physiol Biochem. 45:795–807. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu F, Zhang X, Sun C, Xu W and Xia J:
Downregulation of miRNA-663b protects against hypoxia-induced
injury in cardiomyocytes by targeting BCL2L1. Exp Ther Med.
19:3581–3588. 2020.PubMed/NCBI
|
|
40
|
Cai H, An Y, Chen X, Sun D, Chen T, Peng
Y, Zhu F, Jiang Y and He X: Epigenetic inhibition of miR-663b by
long non-coding RNA HOTAIR promotes pancreatic cancer cell
proliferation via up-regulation of insulin-like growth factor 2.
Oncotarget. 7:86857–86870. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tan Z, Wang C, Li X and Guan F: Bisecting
N-acetylglucosamine structures inhibit hypoxia-induced
epithelial-mesenchymal transition in breast cancer cells. Front
Physiol. 9:2102018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang X, Wang Y, Qian Y, Wu X, Zhang Z,
Liu X, Zhao R, Zhou L, Ruan Y, Xu J, et al: Discovery of specific
metastasis-related N-glycan alterations in epithelial ovarian
cancer based on quantitative glycomics. PLoS One. 9:e879782014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Miwa HE, Koba WR, Fine EJ, Giricz O, Kenny
PA and Stanley P: Bisected, complex N-glycans and galectins in
mouse mammary tumor progression and human breast cancer.
Glycobiology. 23:1477–1490. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Akama R, Sato Y, Kariya Y, Isaji T, Fukuda
T, Lu L, Taniguchi N, Ozawa M and Gu J:
N-acetylglucosaminyltransferase III expression is regulated by
cell-cell adhesion via the E-cadherin-catenin-actin complex.
Proteomics. 8:3221–3228. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Allam H, Johnson BP, Zhang M, Lu Z, Cannon
MJ and Abbott KL: The glycosyltransferase GnT-III activates Notch
signaling and drives stem cell expansion to promote the growth and
invasion of ovarian cancer. J Biol Chem. 292:16351–16359. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yoshimura M, Ihara Y, Ohnishi A, Ijuhin N,
Nishiura T, Kanakura Y, Matsuzawa Y and Taniguchi N: Bisecting
N-acetylglucosamine on K562 cells suppresses natural killer
cytotoxicity and promotes spleen colonization. Cancer Res.
56:412–418. 1996.PubMed/NCBI
|
|
48
|
Yoshimura M, Ihara Y, Nishiura T, Okajima
Y, Ogawa M, Yoshida H, Suzuki M, Yamamura K, Kanakura Y, Matsuzawa
Y and Taniguchi N: Bisecting GlcNAc structure is implicated in
suppression of stroma-dependent haemopoiesis in transgenic mice
expressing N-acetylglucosaminyltransferase III. Biochem J.
331:733–742. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nagae M, Kizuka Y, Mihara E, Kitago Y,
Hanashima S, Ito Y, Takagi J, Taniguchi N and Yamaguchi Y:
Structure and mechanism of cancer-associated
N-acetylglucosaminyltransferase-V. Nat Commun. 9:33802018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Taniguchi N and Kizuka Y: Glycans and
cancer: Role of N-glycans in cancer biomarker, progression and
metastasis, and therapeutics. Adv Cancer Res. 126:11–51. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li J, Xu J, Li L, Ianni A, Kumari P, Liu
S, Sun P, Braun T, Tan X, Xiang R and Yue S: MGAT3-mediated
glycosylation of tetraspanin CD82 at asparagine 157 suppresses
ovarian cancer metastasis by inhibiting the integrin signaling
pathway. Theranostics. 10:6467–6482. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mo C, Liu T, Zhang S, Guo K, Li M, Qin X
and Liu Y: Reduced N-acetylglucosaminyltransferase III expression
via Smad3 and Erk signaling in TGF-β1-induced HCC EMT model. Discov
Med. 23:7–17. 2017.PubMed/NCBI
|
|
53
|
Xu Q, Isaji T, Lu Y, Gu W, Kondo M, Fukuda
T, Du Y and Gu J: Roles of N-acetylglucosaminyltransferase III in
epithelial-to-mesenchymal transition induced by transforming growth
factor β1 (TGF-β1) in epithelial cell lines. J Biol Chem.
287:16563–16574. 2012. View Article : Google Scholar : PubMed/NCBI
|
